Fourth generation QuantiFERON-TB Gold-Plus: What is the evidence?

In this JCM mini review, the authors summarize the performance of QFT-Plus compared with QFT-GIT among active TB patients (a surrogate for LTBI), high-risk populations, and low-risk individuals based on
recent publications.

Shafeque JCM 2020.pdf (534.1 KB)